Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIABASI study of acetylcarnitine in hypertensive patients with type 2 diabetes on simvastatin
2007-005925-31Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM), hypertension (HTN) and dyslipidemia comparing Acetylcarnitine plus background therapy with Placebo plus background therapy (2 arms). Primary endpoint: Systolic blood pressure. Started Mar 2009; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on 2007-005925-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005925-31.